NewsBenzinga오루카, 판상형 건선 치료제 ORKA-001의 2b상 16주차 결과 발표···PASI 100 61%, PASI 90 86% 반응률 기록, 2027년 상반기 3상 진입 예정 오루카, 판상형 건선 치료제 ORKA-001의 2b상 16주차 결과 발표···PASI 100 61%, PASI 90 86% 반응률 기록, 2027년 상반기 3상 진입 예정 Benzinga 2026.10.26 11:13 (GMT+0) Open on Benzinga Other news Billionaires Walk Away From Alphabet in Q3 - Hedge Funds Google ‘How to Sell’ and Hit Enter $100 Invested In Visa 15 Years Ago Would Be Worth This Much Today Western Digital Gains, Seagate Flat As Nvidia’s Raised Outlook Lifts AI Storage Hopes Home Depot Posts Strongest Comps In 4 Years, Analysts Revise Price Targets TJ Maxx Parent Bets on Accelerating Sales This Holiday Season Why Is Coinbase Stock Falling on Wednesday?